Smart Inhalers Market by Product (Inhalers and Nebulizers), Indication (Asthma and COPD), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021 – 2027

ID: VPR/HC/257 Publishing Year: February 2021 Pages: 72 Format:   


Global Smart Inhalers Market was valued at $ XX billion in 2019, and is expected to reach $ XX billion by 2027, registering a CAGR of XX% from 2021 to 2027.

Smart Inhalers are used for the treatment and prevention of respiratory diseases such as asthma and chronic obstructive pulmonary diseases. Smart Inhalers are not same as normal inhalers they have extra digital features such as they link to an app on your phone or tablet using the Bluetooth technology to their mobile apps to help you and your doctor manage your asthma better, they automatically track how often you're using your inhaler, so you don't need to keep your own records. It is used for delivering a variety of medication through inhalation by sensors attached as a clip on to the inhalers monitoring the right dose per intake and the technique used for inhaling the medication. The data acquired by the sensor is shared with the patient and healthcare professionals to track their inhaler usage and can raise reminders and alerts for users.

The factors driving the growth of the Smart Inhalers Market are the increasing prevalence of respiratory disorders, an increase in the rate in patients suffering from asthma and COPD, and lack of healthcare amenities. Smart Inhalers also help in monitoring the technique used for inhaling the medicine in an effective manner as compared to the normal inhalers which help the increasing growth of the market. However, higher costs and the dearth of awareness about the symptoms of COPD and asthma remain untreated are factors hindering the market growth. Furthermore, technology advancement will increase market growth.

Segment Insight:

The Smart Inhalers Market is segmented by product type, application, and distribution channel. Based on product type it is segmented by inhalers, metered-dose inhalers, dry powder inhalers, and nebulizers. Based on the application it is classified into asthma and COPD. Based on distribution channel it is classified by hospitals, retail pharmacies, and online pharmacies.

By Product Type Insight:

Based on product type it is segmented by inhalers, metered-dose inhalers, dry powder inhalers, and nebulizers. Metered inhalers give medication by propellant spray it is a pressurized inhaler. Dry powder inhalers are powder which medicates direct to the lung. Nebulizers give medication in the form of a mist inhaled.

By Application Type Insight:

Based on the application it is asthma and COPD. Asthma is a problem in which the airways narrows and swells and the person suffers from breathing problems. COPD (Chronic obstructive pulmonary disease) is a lung disease.

By Distribution Channel Type Insight:

Based on distribution channel it is segmented by hospitals, retail pharmacies and online pharmacies.

Major Key Players of Smart Inhalers Market:

Adherium, AstraZeneca, Boehringer Ingelheim, Cohero Health, Glaxo Smith Kline, Novartis International AG, Opko Health, ResMed, Inc., Teva Pharmaceutical Industries Limited, and Vectura Group plc.

Most of the key players in Smart Inhalers Market are focusing on business expansion to gain a higher revenue share through the adoption of strategies, such as mergers and acquisitions and new product development.

Smart Inhalers Market Key Segments:

By Product Type

  • Inhalers
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Nebulizers

By Application

  • Asthma
  • COPD

By Distribution Channel

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Turkey
    • South Africa
    • Rest of LAMEA


Frequently Asked Questions
Adherium, AstraZeneca, Boehringer Ingelheim, Cohero Health, Glaxo Smith Kline, Novartis International AG, Opko Health, ResMed, Inc., Teva Pharmaceutical Industries Limited, and Vectura Group plc are the Major Key Players in Smart Inhalers Market.
COPD is the Leading Application Type Segment in the in the Smart Inhalers Market.
Increasing prevalence of respiratory disord and increase in rate in patients suffering from asthma and COPD are the Major Factors Driving the Smart Inhalers Market.

TABLE OF CONTENTS:

CHAPTER 1 MARKET INTRODUCTION

1.1. REPORT OVERVIEW

1.2. SCOPE OF THE STUDY

1.3. PRIMARY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

2.1. C-LEVEL EXECUTIVE’S OVERVIEW AND PERSPECTIVES

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. PRINCIPAL FINDINGS

3.2.1. Key investment pockets

3.2.2. Leading winning strategies

  3.2.3 Key Player Positioning

3.3. PORTERS FIVE FORCES OF COMPETITIVE ANALYSIS

 3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.4.4. Impact Analysis

3.5. IMPACT OF COVID-19 ON THIS MARKET

CHAPTER 4 SMART INHALERS MARKET, BY PRODUCT TYPE

4.1. SYNOPSIS

4.1.1. Market size and forecast

  4.2. INHALERS

 4.2.1. Key market trends

4.2.2. Growth factors and opportunities

  4.2.3. Market size and forecast

4.3. METERED DOSE INHALERS

4.3.1. Key market trends

4.3.2. Growth factors and opportunities

  4.3.3. Market size and forecast

  4.4. DRY POWDER INHALERS

4.4.1. Key market trends

4.4.2. Growth factors and opportunities

  4.4.3. Market size and forecast

4.5. NEBULIZERS

4.5.1. Key market trends

4.5.2. Growth factors and opportunities

  4.5.3. Market size and forecast

CHAPTER 5 SMART INHALERS MARKET, BY APPLICATION

  • 5.1 SYNOPSIS 

5.1.1. Market size and forecast

  • 5.2 ASTHMA

5.2.1. Key market trends

5.2.2. Growth factors and opportunities

5.2.3. Market size and forecast

  • 5.3 COPD

5.3.1. Key market trends

5.3.2. Growth factors and opportunities

5.3.3. Market size and forecast

CHAPTER 6 SMART INHALERS MARKET, BY INDUSTRY

  • 6.1. SYNOPSIS

6.1.1. Market size and forecast

  • 6.2. HOSPITALS

6.2.1. Key market trends

6.2.2. Growth factors and opportunities

6.2.3. Market size and forecast

  • 6.3. RETAIL PHARMACIES

6.3.1. Key market trends

6.3.2. Growth factors and opportunities

6.3.3. Market size and forecast

  • 6.4. ONLINE PHARMACIES

6.4.1. Key market trends

6.4.2. Growth factors and opportunities

6.4.3. Market size and forecast

CHAPTER 7 SMART INHALERS MARKET, BY REGION

7.1 SYNOPSIS

7.2 North America

7.2.1 Key market trends

7.2.2 Competitive scenario

7.2.3 Key growth factors and opportunities

7.2.4 Market size and forecast

7.3 Europe

7.3.1 Key market trends

7.3.2 Competitive scenario

7.3.3 Key growth factors and opportunities

7.3.4 Market size and forecast

7.4 Asia Pacific

7.4.1 Key market trends

7.4.2 Competitive scenario

7.4.3 Key growth factors and opportunities

7.4.4 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends

7.5.2 Key growth factors and opportunities

7.5.3 Market size and forecast

CHAPTER 8 COMPANY PROFILES

  8.1. ADHERIUM

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Product portfolio

8.1.4. Business performance

8.1.5. Key strategic moves and developments

8.2. ASTRAZENECA

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Product portfolio

8.2.5. Business performance

8.2.6. Key strategic moves and developments

8.3. BOEHRINGER INGELHEIM

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product portfolio

8.3.5. Business performance

8.3.6. Key strategic moves and developments

8.4. COHERO HEALTH

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product portfolio

8.4.5. Business performance

8.4.6. Key strategic moves and developments

8.5.  GLAXO SMITH KLINE

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product portfolio

8.5.5. Business performance

8.5.6. Key strategic moves and developments

8.6. NOVARTIS INTERNATIONAL AG

8.6.1. Company overview

8.6.2. Company Snapshot

8.6.3. Operating business segments

8.6.4. Product portfolio

8.6.5. Business performance

8.6.6. Key strategic moves and developments

8.7. OPKO HEALTH

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Business performance

8.7.6. Key strategic moves and developments

8.8. RESMED, INC

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product portfolio

8.8.5. Business performance

8.8.6. Key strategic moves and developments

8.9. TEVA PHARMACEUTICAL INDUSTRIES LIMITED

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product portfolio

8.9.5. Business performance

8.9.6. Key strategic moves and developments

8.10. VECTURA GROUP PLC

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

8.10.5. Business performance

8.10.6. Key strategic moves and developments


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]